Search research articles
Contact Us
Filters
Showing results (191-200 of 222) with videos related to
Page
of 23
Sort By:
Journal of Hepatology
|
July 8, 2020
Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta
Dominique Roulot, Ségolène Brichler, Richard Layese, et al.
Gastro Hep Advances
|
February 17, 2022
Validation of the Performance of A1HPV6, a Triage Blood Test for the Early Diagnosis and Prognosis of SARS-CoV-2 Infection
Pauline Maisonnasse, Thierry Poynard, Mehdi Sakka, et al.
Frontiers in Genetics
|
November 22, 2019
Identification of an Endoglin Variant Associated With HCV-Related Liver Fibrosis Progression by Next-Generation Sequencing
Frédégonde About, Stéphanie Bibert, Emmanuelle Jouanguy, et al.
Gastroenterology
|
March 23, 2011
Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C
Jordi Bruix, Thierry Poynard, Massimo Colombo, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
July 29, 2017
Cystic Fibrosis-related Liver Disease: Research Challenges and Future Perspectives
Dominique Debray, Michael R Narkewicz, Frank A J A Bodewes, et al.
Gut
|
July 1, 2010
Interferon gamma receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis C infection
Bertrand Nalpas, Roubila Lavialle-Meziani, Sabine Plancoulaine, et al.
Annals of Internal Medicine
|
February 5, 2009
Immediate listing for liver transplantation versus standard care for Child-Pugh stage B alcoholic cirrhosis: a randomized trial
Claire Vanlemmens, Vincent Di Martino, Chantal Milan, et al.
Gastroenterology
|
February 12, 2009
Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy
Thierry Poynard, Massimo Colombo, Jordi Bruix, et al.
Hepatology (Baltimore, Md.)
|
June 25, 2016
A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients
Damien Ulveling, Sigrid Le Clerc, Aurélie Cobat, et al.
Journal of Hepatology
|
November 9, 2010
FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC³ program
Thierry Poynard, Mona Munteanu, Massimo Colombo, et al.
Page
of 23
Search research articles
Search
Showing results (191-200 of 222) with videos related to
Sort By:
Page
of 23
Journal of Hepatology
|
July 8, 2020
Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta
Dominique Roulot, Ségolène Brichler, Richard Layese, et al.
Gastro Hep Advances
|
February 17, 2022
Validation of the Performance of A1HPV6, a Triage Blood Test for the Early Diagnosis and Prognosis of SARS-CoV-2 Infection
Pauline Maisonnasse, Thierry Poynard, Mehdi Sakka, et al.
Frontiers in Genetics
|
November 22, 2019
Identification of an Endoglin Variant Associated With HCV-Related Liver Fibrosis Progression by Next-Generation Sequencing
Frédégonde About, Stéphanie Bibert, Emmanuelle Jouanguy, et al.
Gastroenterology
|
March 23, 2011
Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C
Jordi Bruix, Thierry Poynard, Massimo Colombo, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
July 29, 2017
Cystic Fibrosis-related Liver Disease: Research Challenges and Future Perspectives
Dominique Debray, Michael R Narkewicz, Frank A J A Bodewes, et al.
Gut
|
July 1, 2010
Interferon gamma receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis C infection
Bertrand Nalpas, Roubila Lavialle-Meziani, Sabine Plancoulaine, et al.
Annals of Internal Medicine
|
February 5, 2009
Immediate listing for liver transplantation versus standard care for Child-Pugh stage B alcoholic cirrhosis: a randomized trial
Claire Vanlemmens, Vincent Di Martino, Chantal Milan, et al.
Gastroenterology
|
February 12, 2009
Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy
Thierry Poynard, Massimo Colombo, Jordi Bruix, et al.
Hepatology (Baltimore, Md.)
|
June 25, 2016
A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients
Damien Ulveling, Sigrid Le Clerc, Aurélie Cobat, et al.
Journal of Hepatology
|
November 9, 2010
FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC³ program
Thierry Poynard, Mona Munteanu, Massimo Colombo, et al.
Page
of 23